These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5570924)

  • 1. Absorption and dissolution characteristics of 14 different oral chloramphenicol preparations tested on healthy human male subjects.
    Bel H; Johansen H; Lunde PK; Andersgaard HA; Finholt P; Midtvedt T; Holum E; Martinussen B; Aarnes ED
    Pharmacology; 1971; 5(2):108-20. PubMed ID: 5570924
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma chloramphenicol levels in dogs after the administration of four different oral preparations of chloramphenicol.
    Watson AD
    Aust Vet J; 1973 Oct; 49(10):460-2. PubMed ID: 4774387
    [No Abstract]   [Full Text] [Related]  

  • 3. [Investigation of the absorption of orally administered chloramphenicol preparations].
    Finholt P; Lunde PK; Midtvedt T; Aarnes ED
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1245-6. PubMed ID: 5565809
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of dosage form on drug effect].
    Zathurecký L
    Pharmazie; 1972 Nov; 27(11):686-93. PubMed ID: 4650983
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum levels of chloramphenicol in children, rhesus monkeys, and cats after administration of chloramphenicol palmitate suspension.
    Banerjee S; Bandyopadhyay A; Bhattacharjee RC; Mukherjee AK; Halder AK
    J Pharm Sci; 1971 Jan; 60(1):153-5. PubMed ID: 4994065
    [No Abstract]   [Full Text] [Related]  

  • 6. [The consequence of the preparation factors for the effect of the drug].
    Johnsgård M; Pedersen AO
    Tidsskr Nor Laegeforen; 1973 Apr; 93(10):698-703. PubMed ID: 4755086
    [No Abstract]   [Full Text] [Related]  

  • 7. Rate studies on in vitro dissolution and in vivo absorption of chloramphenicol.
    Andersgaard H; Finholt P; Gjermundsen R; Hoyland T
    Acta Pharm Suec; 1971 Sep; 8(4):403-14. PubMed ID: 5135174
    [No Abstract]   [Full Text] [Related]  

  • 8. Dissolution-Hollow Fiber Membrane (D-HFM) System to Anticipate Biopharmaceutics Risk of Tablets and Capsules.
    Adhikari A; Seo PR; Polli JE
    J Pharm Sci; 2023 Mar; 112(3):751-759. PubMed ID: 36202250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioavailability of levomycetin preparations for oral use].
    Batuashvili TA; Zak AF
    Antibiotiki; 1983 Oct; 28(10):751-4. PubMed ID: 6651263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New in vitro disintegration and dissolution test method for tablets and capsules.
    Goodhart FW; McCoy RH; Ninger FC
    J Pharm Sci; 1973 Feb; 62(2):304-10. PubMed ID: 4686409
    [No Abstract]   [Full Text] [Related]  

  • 13. Generic inequivalence--clinical observations.
    Prescott LF; Nimmo J
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():288-303. PubMed ID: 5317801
    [No Abstract]   [Full Text] [Related]  

  • 14. Acid-labile derivatives of chloramphenicol as potential latentiation forms.
    Gillet AD; Abdel-Monem MM
    J Med Chem; 1973 Sep; 16(9):992-5. PubMed ID: 4745515
    [No Abstract]   [Full Text] [Related]  

  • 15. An evaluation of the biological availability of chloramphenicol.
    Koeleman HA; Van Oudtshoorn MC
    S Afr Med J; 1973 Jan; 47(3):94-9. PubMed ID: 4631423
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of pharmaceutical and physico-chemical factors of drugs on the result of clinical trials: chloramphenicol palmitate].
    van Oudtshoorn MC; Potgieter FJ; Koeleman HA; Pantonowitz LD
    S Afr Med J; 1969 Nov; 43(45):1375-6. PubMed ID: 4902056
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability of nifedipine from different oral dosage forms in healthy volunteers.
    Leucuţa SE; Vida-Simiti L; Căprioară MG; Făgărăşan E; Olinic N; Manasia M; Vlaicu R
    Pharmazie; 1989 May; 44(5):336-8. PubMed ID: 2772014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-dependent dissolution rate of nitrofurantoin from commercial suspensions, tablets, and capsules.
    Bates TR; Young JM; Wu CM; Rosenberg HA
    J Pharm Sci; 1974 Apr; 63(4):643-5. PubMed ID: 4828728
    [No Abstract]   [Full Text] [Related]  

  • 19. [Formulation and operative factors in relation to the physiological availabiltiy of drugs in oral preparations].
    Guadagnini G; Neri G; Rugginenti GC; Vannini E
    Boll Chim Farm; 1973 Nov; 112(11):719-33. PubMed ID: 4786711
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Penicillins: use of an animal model to predict bioavailability.
    Poole JW
    Rev Can Biol; 1973; 32():Suppl:43-51. PubMed ID: 4204778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.